Extract
Bioxel Pharma Completes a Private Placement of $4.7M.
STE-FOY, Quebec -- Bioxel Pharma Inc. (TSX VENTURE:BIP) a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, announced today that it has completed a private placement of 13,817,366 common shares at a price of $0.34 per share, f...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
@Road Appoints Michael Johnson as Chief Financial Officer Johnson Brings More Than 20 Years... | North American Scientific to Host Conference Call on Second-Quarter Financial Results. | ScanSoft Named Market Leader in Asia Pacific Speech Recognition Market. | Draegerwerk AG H1/2003 Performance. | Decisión de Tribunal Quinto de Primera Instancia en Funciones de Control de Tachira Extensión San Cris... | Decisión de Juzgado Cuarto de Primera Instancia de Sustanciación, Mediación y Ejecución del Trabajo de Tachira (Extensión San C... | Decisión de Juzgado Segundo de los Municipios Cabimas, Santa Rita y Simón Bolivar de Zulia, de July 02, 2004 | Sentencia nº 110 de Consiglio di Stato, January 13, 2009
